A TNFR2 biparatopic antagonist reverses immune suppression through a crosslinking-resistant and ADCC- independent mechanism.

BI-1808 - BioInvent

http://www.ncbi.nlm.nih.gov/pubmed/42341157

Fei Chen; Jinli Xie; Kai Yu; Shusu Liu; Yijie Gao; Zhichao Eric Ai; Zhipeng Yan; Zhongzhou Zheng

Jun 25, 2026